BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Mergers and Acquisitions
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property 11/25/2014
BioMarin Pharmaceutical Inc. (BMRN) Acquires ProSensa Holding N.V. (RNA) For Up To $840M; Gaining Experimental Drisapersen 11/24/2014
AbbVie (ABBV) Acquires Manufacturing Facility In Singapore; Further Expands Capabilities In Asia 11/21/2014
EXCLUSIVE: Ackman Says “Biggest Mistake” In Allergan (AGN) Bid Was Tender Offer 11/21/2014
Apellis Pharmaceuticals To Acquire Potentia Pharmaceuticals, Inc. 11/20/2014
Knight Therapeutics Sells Priority Review Voucher To Gilead Sciences, Inc. (GILD) For US$125 Million Cash 11/20/2014
The Rohatyn Group Completes Sale of 36.6% Huvepharma Stake To Advance Properties 11/20/2014
Migranade, Inc., The Maker Of MIGRANADE Migraine Relief, Acquires Oasis Health Care Products, Inc. 11/19/2014
Endo Pharmaceuticals (ENDP) Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals (AUXL) 11/19/2014
Actavis (ACT) Agrees To Buy Allergan (AGN) For $66 Billion 11/18/2014
Ricerca Biosciences, LLC Release: Acquired By Growth-Oriented Equity Investment Group 11/18/2014
Actavis (ACT) To Acquire Allergan Inc. (AGN) To Create Top 10 Global Growth Pharmaceutical Company With $23 Billion In Revenue 11/17/2014
Valeant (VRX) Buys Nicox In $20 Million Deal 11/17/2014
Zoetis (ZTS) To Purchase Assets Of Abbott Animal Health 11/17/2014
Actavis (ACT) In Talks To Buy Allergan Inc. (AGN) For Over $60 Billion 11/14/2014
Deal-Hungry Pfizer (PFE) Unlikely To Make Fresh Bid For AstraZeneca PLC (AZN) 11/14/2014
PE Firm To Bid For GlaxoSmithKline (GSK)'s $3 Billion Mature Drugs Portfolio 11/14/2014
Jubilant Life Sciences (JOL) Seeks To Complete Buyout Of U.S.-Based Cadista For Up To $33.2 Million 11/14/2014
Recipharm AB Bags Lusomedicamenta For $140 Million 11/14/2014
Sanofi (SAN.PA) Unloads Large Office In India 11/13/2014
Zoetis (ZTS) May Be Valeant (VRX)'s Plan B 11/13/2014
Nuvo Research Inc. (NRI.TO) Reacquires Pennsaid® 2% Rights To South America, Central America, South Africa And Israel 11/13/2014
AMAG Pharmaceuticals, Inc. (AMAG) Completes Acquisition Of Lumara Health's Maternal Health Business 11/13/2014
Ackman Takes $2 Billion Stake In Zoetis (ZTS) 11/12/2014
Thailand-Based SCG Acquires Stake In Liechtenstein-Based Research Company Lysando AG 11/12/2014
AstraZeneca PLC (AZN) Is Building Value Without Pfizer (PFE): CEO 11/11/2014
Johnson & Johnson (JNJ) Chief Eyes Acquisitions In China 11/10/2014
Johnson & Johnson (JNJ) Announces Completion Of Alios BioPharma Acquisition 11/10/2014
PDL BioPharma, Inc. (PDLI) Pays $65.6 Million For Portion Of University of Michigan's Royalty Interest In Genzyme Corporation (GENZ) Drug 11/7/2014
UCB Group (UCBJF.PK) Divests U.S. Generics Unit For $1.53 Billion 11/7/2014
VWR, Inc. Acquires Integra Companies, Inc. And STI Components, Inc. 11/7/2014
Laboratory Corporation of America Holdings (LabCorp) (LH) Snatches Up Covance Inc. (CVD) For $6.1 Billion 11/6/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Pays $325 Million Upfront For AstraZeneca PLC (AZN)'s Myalept™ 11/6/2014
Perrigo Company (PRGO) Snatches Up Omega Pharma NV (0OMEP.BR) For $4.5 Billion 11/6/2014
Eurofins Acquires SF Analytical Labs Increasing Midwest Footprint 11/6/2014
Instem Release: Leading Chinese Research Institute Purchases Provantis Preclinical Software Solution For Shanghai Headquarters 11/6/2014
GVK BIO Signs Definitive Agreement To Acquire Vanta Bioscience 11/6/2014
ERT Announces Acquisition Of eClinical Insights 11/6/2014
Allergan Inc. (AGN) Confirms Second Suitor Wants To Buy It, Is It Actavis (ACT)? 11/5/2014
AstraZeneca PLC (AZN) Builds Cancer Immunotherapy Capabilities With $150 Million Definiens AG Buy 11/4/2014
Cantel Medical (CMN) Acquires International Medical Service S.r.l. 11/4/2014
NEMUS Completes Reverse Merger With Load Guard Logistics, Inc. 11/4/2014
Taiyo Pacific Partners Becomes Major Shareholder In Peptidream With Stake Over 5% 11/4/2014
Univar Expands in Brazil Market With Acquisition Of D'Altomare Quimica Ltda. 11/4/2014
Sigma-Aldrich Corporation (SIAL) Completes Acquisition Of Cell Marque 11/4/2014
AbbVie (ABBV)'s Strong Results Lessen Need For Big Deal 11/3/2014
AbbVie (ABBV) Not Looking For Massive Deals After Abandoning Shire 11/3/2014
Actavis (ACT) And Durata Therapeutics, Inc.  (DRTX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Durata 11/3/2014
Mesa Labs (MLAB) Acquires Its UK And Irish Republic Distributor Of Biological Indicators 11/3/2014
Deal-Starved Perrigo Company (PRGO) In Exclusive Talks To Buy $5 Billion+ Omega Pharma NV (0OMEP.BR) 10/31/2014
AVANIR Pharmaceuticals (AVNR) Gives Suitors Two Big Reasons To Bid 10/31/2014
Sterigenics International, Inc. Continues Growth With Acquisition Of Leading Italian Sterilization Firm 10/31/2014
Paratek Pharmaceuticals, Inc. Completes Merger With Transcept Pharmaceuticals, Inc. (TSPT) 10/31/2014
Bayer AG (BAYZF) Hunts For More Deals After Bulking Up Consumer Care 10/30/2014
Abbott Laboratories (ABT) Pays $250 Million For Menlo Park Startup Topera 10/30/2014
PDI, Inc. (PDII) Confirms Receipt Of Unsolicited Acquisition Proposal From Digirad Corporation (DRAD) 10/30/2014
PerkinElmer, Inc. (PKI) Acquires Ceiba Solutions, Inc. 10/30/2014
Novartis AG (NVS) Sells Flu Vaccine Business For $275 Million To CSL Limited (CMXHF.PK) 10/28/2014
Valeant (VRX): We Will Bump Allergan Inc. (AGN) Offer To $200 A Share 10/28/2014
Luye Pharma Pays $390 Million For Remaining 42% Of Beijing Jialin Pharma 10/28/2014
Pfizer (PFE)'s $11 Billion Buyback Dims Prospects Of AstraZeneca PLC (AZN) Bid 10/27/2014
Zogenix, Inc. (ZGNX) Snags U.K.-Based Brabant Pharma In $35 Million Cash-Stock Deal 10/27/2014
CTI BioPharma Grabs Exclusive Worldwide Rights To Tosedostat 10/27/2014
Allergan Inc. (AGN) Comments On Valeant (VRX) Letter 10/27/2014
Institutional Investor Lincoln Park Capital Increases Ownership In Anavex Life Sciences Corp. (AVXL.OB), Pays Over 25% Premium To Market 10/27/2014
MPI Research Acquires Jasper Clinical Research & Development 10/27/2014
Private Equity Eyes $13 Billion Bayer AG (BAYZF)'s Plastics Business 10/24/2014
New Actavis (ACT) CEO Has $70 Billion In Deals To Choose From 10/24/2014
Mylan Inc. (MYL), Abbott Laboratories (ABT) Tweak $5 Billion Tax Inversion Deal 10/23/2014
Acorda Therapeutics (ACOR) Completes Acquisition Of Civitas Therapeutics 10/23/2014
Actavis (ACT) Pays $40 Million Upfront; Snags Option To Buy Rhythm Health 10/22/2014
BioNano Genomics's Irys System Adopted By Leading Genomics Centers For Comprehensive Detection Of Human Genome Structural Variation 10/22/2014
Ferring Pharmaceuticals To Acquire Marketing Rights For DDAVP® (desmopressin) Product Portfolio From Sanofi (SAN.PA) 10/22/2014
AbbVie (ABBV) Officially Abandons Shire 10/21/2014
Shire Goes Shopping After AbbVie (ABBV) Deal Falls Through 10/21/2014
Valeant (VRX) Hints At Higher Bid For Allergan Inc. (AGN) 10/21/2014
Lupin Ltd. (LUPN.BO) Scouts For Acquisitions In U.S. 10/21/2014
Actavis (ACT) Will Compete With Sanofi (SAN.PA) For $5.1 Billion Omega Pharma NV (0OMEP.BR) Deal 10/21/2014
Nanion Release: Prestigious Academic Facility At Northwestern University Acquires The SyncroPatch 384/768PE 10/21/2014
Therapix Signs Non-Binding Agreement to Acquire Dekel Pharmaceuticals Ltd. 10/21/2014
Medican Enterprises Signs Binding Letter Of Intent To Acquire Indoor Growing And Hydroponic Equipment Manufacturer Future Harvest Development 10/21/2014
BioProcess Technology Consultants, Inc. Acquires CTD Quality Consulting, Launches New advanceONE™ Division 10/20/2014
Fresenius AG, Buyout Groups Eye Danone Medical Nutrition Unit 10/20/2014
Lawyers Have Documents That Prove Allergan Inc. (AGN) Misled Investors About Valeant (VRX): Ackman 10/17/2014
AbbVie (ABBV) Board Officially Abandons $55 Billion Shire Merger 10/17/2014
Virax To Acquire Deep AKT Inhibitor Portfolio Already In Phase 1b/2 Breast & Phase 1b Ovarian Cancer Trials 10/17/2014
DiaGenic ASA: Completed Acquisition Of NEL Hydrogen – Company Name And Ticker To Be Changed 10/17/2014
Horizon Biopharm Pays $45 Million Cash For U.S. Rights To PENNSAID® 2% 10/17/2014
Shire Plummets As AbbVie (ABBV) Reconsiders $55 Billion Takeover Bid 10/16/2014
MorphoSys AG Acquires Lanthipeptide Technology From Lanthio Pharma 10/15/2014
Geographic Split Likely For GlaxoSmithKline (GSK) Mature Drugs Sale 10/15/2014
Analysts Still See AstraZeneca PLC (AZN) As Viable Takeover Target 10/15/2014
Spotlight Innovation Signs Letter Of Intent To Acquire Memcine Pharmaceuticals 10/15/2014
Princeton University Acquires Protea Biosciences, Inc.'s LAESI® Technology Platform 10/15/2014
Fosun International Ltd. Pays $607 Million For Portuguese Hospital Chain 10/13/2014
Oxford BioMedica PLC (OXB.L) Acquires Windrush Court Office And Laboratory Facilities 10/13/2014
Becton, Dickinson and Company (BDX) Acquires GenCell Biosystems 10/13/2014
Bay Area's IMPAX Laboratories, Inc. (IPXL) Snags Two Private Drugmakers For $700 Million Cash 10/10/2014
Fidelity Ups Its Stake In Allergan Inc. (AGN) As Actavis (ACT) Bid Rumors Fly; Potential $60 Billion Deal 10/10/2014
Valeant (VRX) Will Sweeten Allergan Inc. (AGN) Bid To Clinch Deal 10/9/2014
Endo International plc (ENDP) Pays $2.6 Billion For Auxilium Pharmaceuticals (AUXL), Auxilium Drops QLT Inc. (QLTI) Deal 10/9/2014
Roche (RHHBY) Acquires Rights To Technology And Patent Applications From Abvitro To Support Next-Generation Sequencing Pipeline 10/9/2014
GlaxoSmithKline (GSK) Takes A 25% Stake In Aspen Pharmacare Ltd. Japanese Unit 10/9/2014
QLT Inc. (QLTI) Announces Merger With Auxilium Pharmaceuticals (AUXL) Terminates For Superior Proposal 10/9/2014
Actavis (ACT) Plots New Merger Approach For Allergan Inc. (AGN) 10/8/2014
DiaGenic ASA Signed Final Agreement To Acquire NEL Hydrogen AS – Extended Announcement 10/8/2014
Analyst Dismisses Teva Pharmaceutical Industries Limited (TEVA)-Mylan Inc. (MYL) Merger Rumor 10/7/2014
Top Managers Argue Over What To Do With Sanofi (SAN.PA)'s $8 Billion Drug Portfolio 10/7/2014
Teva Pharmaceutical Industries Limited (TEVA) To Stop R&D In Cancer And Women's Health; 14 Pipeline Projects To End, Divest 10/7/2014
Cognizant (CTSH) Acquires Cadient Group To Help Clients Drive Business Transformation Through Digital Technologies 10/7/2014
Actavis (ACT) Finally Makes A Move, Pays $675 Million For Durata Therapeutics, Inc.  (DRTX) 10/6/2014
Week in Review: WuXi PharmaTech Co., Ltd. Acquires XenoBiotic Laboratories, Inc. , A US-China CRO 10/6/2014
Arbor Pharmaceuticals Explores $1 Billion+ Sale 10/3/2014
Salix Pharmaceuticals, Ltd. (SLXP) Linked With Actavis (ACT) After Calling Off Cosmo Pharmaceuticals S.p.A. Merger Amid Inversion Crackdown 10/3/2014
Soluble Therapeutics Grabs Seattle-Based Biotech Dilyx Biotechnologies 10/3/2014
PAREXEL International (PRXL) Announces Acquisition Of Clinintel, Extending Leadership In Randomization And Trial Supply Management 10/3/2014
Immutep S.A. Picks Up Prima Biomed (PRR.AX) For $28 Million 10/2/2014
Sagent Pharmaceuticals, Inc. Bags Omega Laboratories For $85.3 Million Cash 10/2/2014
Stemgent, Inc. Sells The Stem Cell Reagent And Services Business Unit 10/2/2014
The Dow Chemical Company (DOW) Provides Updates On Planned Divestments Progress And Outlines Additional Portfolio Actions 10/2/2014
Novasep To Sell Its Bahamian Plant To Local Investor 10/2/2014
Catalent Pharma Solutions (CTLT) Expands Its Technology Offerings In Biologics, Acquires Redwood Bioscience Inc. And The SMARTag™ Technology Platform 10/2/2014
Prima Biomed (PRR.AX) Secures $37.4 Million To Fund Immutep S.A. Acquisition 10/2/2014
Neogen Corporation (NEOG) Acquires BioLumix 10/2/2014
Consort Medical Scoops Up Aesica For $374 Million 10/1/2014
Akorn, Inc. (AKN) Ponies Up $45 Million Cash For Sunovion Pharmaceuticals Inc.'s Xopenex® (levalbuterol HCI) Inhalation Solution 10/1/2014
Johnson & Johnson (JNJ) Bags SSF's Alios BioPharma For $1.7 Billion Cash 10/1/2014
Merck & Co. (MRK) Completes Sale Of Consumer Care Business To Bayer AG (BAYZF) For $14.2 Billion 10/1/2014
Recipharm AB Completes Acquisition Of Corvette Pharmaceutical Services Group For SEK1.1 Billion 10/1/2014
Harvard Bioscience Inc. (HBIO) Acquires Multi Channel Systems MCS GmbH And Triangle BioSystems, Inc. 10/1/2014
WuXi PharmaTech Co., Ltd. Laboratory Testing Division Expands In U.S. With Acquisition Of XenoBiotic Laboratories, Inc. 10/1/2014
Islet Sciences, BHV Pharma, Inc. Merges; Combined Company To Be Named Avogenx 10/1/2014
Oncore Grabs Enantigen Therapeutics For Undisclosed Amount 10/1/2014
After Snagging 18 Products From AstraZeneca PLC (AZN), IGI Laboratories, Inc. Grabs Two More From Valeant (VRX) 10/1/2014
Chindex International, Inc. (CHDX) Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 9/30/2014
Strides Arcolab Limited Snags Shasun Pharma In All Stock Deal Worth Over $221 Million 9/30/2014
Cellular Biomedicine Group (CBMG) Completes Acquisition Of Agreen Biotech Co Ltd. 9/30/2014
AMAG Pharmaceuticals, Inc. (AMAG) Shells Out $675 Million For Women's Health Company Lumara Health 9/29/2014
Life Sciences M&A Stays White Hot As Buying Spree Continues 9/29/2014
Hikma Pharmaceuticals Eyeing $1 Billion Bid For U.S. Rival CorePharma LLC 9/29/2014
Daiichi Sankyo, Inc. (4568.t) Boosts Cancer Pipeline With $410 Million Ambit Biosciences Buy 9/29/2014
Ex-Elan Corporation PLC (ELN) Trio Snags Their Former Employer’s Kinase Inhibitor Program 9/29/2014
Chiltern International Ltd. Acquires Pacific Clinical Research Pte Limited And Expands Operations And Therapeutic Depth In Asia-Pacific 9/29/2014
Abbott Laboratories (ABT) Completes Acquisition Of CFR Pharmaceuticals; Announces Results Of Tender Offer For CFR Shares 9/26/2014
Scleroderma Foundation Of Southern California And Greater San Diego Chapter Merge To Enhance Support And Education For Scleroderma Patients 9/25/2014
Cambridge Healthtech Institute Announces The Acquisition Of OpenHelix 9/25/2014
PPD, Inc. (PPDI) Exercises Option To Acquire Remaining Interest In X-Chem 9/25/2014
Allergan Inc. (AGN) Issues Statement Regarding Recent Valeant Pharmaceuticals International (VRX) Correspondence 9/25/2014
IGI Laboratories, Inc. Scores Eighteen Former Products From AstraZeneca PLC (AZN) 9/25/2014
Acorda Therapeutics (ACOR) Snaps Up Civitas Therapeutics In $525M Cash Deal 9/24/2014
Pfizer (PFE) Approached Actavis (ACT) For Possible Merger 9/24/2014
Bionomics Limited (BNO.AX) Acquires Prestwick Chemical 9/23/2014
Merck KGaA (MKGAF.PK) To Pay $17 Billion For St. Louis-Based Sigma-Aldrich Corporation (SIAL) 9/23/2014
Allergan Inc. (AGN) Rejected Actavis (ACT), Continues Courting Salix Pharmaceuticals, Ltd. (SLXP) 9/23/2014
NovaDel Pharma (NVD) Announces The Sale Of Its Zolpimist® New Drug Application, License And Intellectual Property To Amherst Pharmaceuticals 9/22/2014
Allozyne, Inc. Sold For Scrap As MedImmune (AZN) Snaps Up Rights 9/22/2014
Auxilium Pharmaceuticals (AUXL) Rejects $2.2B Bid From Endo International plc (ENDP), While QLT Inc. (QLTI) Merger Looks More Likely 9/22/2014
Horizon Pharma plc.  (HZNP) Completes Acquisition Of Vidara Therapeutics 9/22/2014
PCI Significantly Expands Global Clinical Services Business Through Biotec Acquisition 9/19/2014
Cambridge Healthtech Institute & Knowledge Foundation Acquire The International Battery Seminar & Exhibition 9/18/2014
Salix Pharmaceuticals, Ltd. (SLXP) Faces Shareholder Revolt On Cosmo Pharmaceuticals S.p.A. Deal 9/17/2014
Auxilium Pharmaceuticals (AUXL) Institutes "Poison Pill" To Fend Off $2.2B Endo Pharmaceuticals (ENDP) Offer 9/17/2014
Asian Investor In Talks To Buy, Build Massive Burlingame Site; Will It Hold Biotech Or Tech Tenants? 9/17/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Buys Rights To Tildrakizumab From Merck & Co. (MRK) For An Upfront Payment Of $80 Million 9/17/2014
Hikma Pharmaceuticals Completes Acquisition Of Ben Venue Laboratories Manufacturing Site 9/17/2014
QLT Inc. (QLTI) Provides Update On Merger With Auxilium Pharmaceuticals (AUXL) 9/17/2014
Denovo Biopharma Acquires Late-Stage Oncology Drug From Eli Lilly and Company (LLY) For Development As A Personalized Medicine 9/17/2014
Akashi Therapeutics Acquires Global Rights To Novel DMD Treatment From Tonus Therapeutics 9/15/2014
Google Inc. Dives Deeper Into Biotech With Lift Labs Acquisition 9/15/2014
More Than 35% Of Allergan Inc. (AGN) Investors Demand Special Meeting; Support For Valeant (VRX) Merger Grows 9/12/2014
Illinois-Based Akorn, Inc. (AKN) Eyes $2 Billion UCB SA Unit In Potential Tax Inversion Deal 9/12/2014
Sanofi (France) (SAN.PA) Aims For M&A With Genzyme Corporation (GENZ) 9/12/2014
Mergers Hamper Innovation, Ex-Pfizer (PFE) Top Exec Says 9/11/2014
Mylan Inc. (MYL) Scoops Up Injectable Arixtra For $300 Million From Aspen Global Inc. 9/10/2014
Kolltan Pharmaceuticals Inc. Acquires Xetrios Therapeutics And Exclusive Rights To Salk Institute for Biological Studies Patents Related To The TAM Receptor Tyrosine Kinase Family 9/10/2014
VWR International, LLC Expands European Tissue Diagnostics Portfolio With Acquisition Of Klinipath BV 9/10/2014
Jazz Pharmaceuticals plc (JAZZ) Stock Up On Allergan Inc. (AGN) Rumor 9/9/2014
ReproCELL Acquires The iPS Cell Business Unit Of Stemgent, Inc. 9/9/2014
Kinex Pharmaceuticals Completes Acquisition Of QuaDPharma 9/9/2014
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, Acquires The Ownership Of Three Soft Gel ANDA's From Par Pharmaceutical, Inc. 9/9/2014
Medican Moves Toward Closing The Purchase Of 51 Percent Of International Herbs Medical Marijuana Ltd. (IHMML) 9/8/2014
Envision Pharmaceutical Completes Its Acquisition Of Medtrak Services 9/8/2014
Neos Therapeutics Acquires All Commercialization And Profit Rights To Generic Tussionex® (Extended Release Hydrocodone Polistirex/Chlorpheniramine Polistirex) From Chiesi USA And Coating Place, Inc. 9/8/2014
Momenta Pharmaceuticals, Inc. (MNTA) Exercises Option To Acquire Novel Antibodies From AnaptysBio, Inc. 9/8/2014
WellSpring Pharmaceutical Corporation Acquires BONINE®, An Over-The-Counter Drug For Motion Sickness, From Prestige Brands, Inc. 9/5/2014
Soligenix (SNGX) Expands Pipeline With Acquisition Of Phase 3-Ready Oncology Clinical Program 9/5/2014
China Biologic Products Completes Transaction To Acquire Additional Equity Stake In Guizhou Taibang 9/4/2014
Cellectis (ALCLS) Announces The Closing Of The Sale Of Its Swedish Subsidiary Cellectis AB To Takara Bio 9/4/2014
DPT Laboratories, Ltd. Acquires Meda Pharmaceuticals’ Lakewood, New Jersey, Location 9/4/2014
Mercachem Holding B.V. To Acquire Prague Business From Synthon 9/3/2014
MWI Veterinary Supply Acquires Vetspace 9/3/2014
Eisai Inc. (ESALF.PK) Sells U.S. Rights To Zonegran® (zonisamide) Capsules To Concordia Pharmaceuticals 9/3/2014
Albemarle Corporation (ALB) Completes Sale Of Antioxidant, Ibuprofen And Propofol Businesses To SI Group 9/3/2014
PPD, Inc. (PPDI) Acquires RCT Logic’s Exclusive License To Patented Clinical Trial Design Technology 9/3/2014
AstraZeneca PLC (AZN) Pops On Possibility Of Another Pfizer (PFE) Bid; Start Of New Cancer Trial 9/2/2014
BioLegend Acquires The Antibody Products Business Unit From Covance Inc. (CVD) 9/2/2014
Johnson & Johnson (JNJ) Seeks Buyer For Struggling Medical Device Unit Cordis Corporation (JNJ); Deal Could Fetch Up To $2 Billion 8/29/2014
Bayer AG (BAYZF), Boehringer Ingelheim Corporation, Perrigo Company (PRGO), And Sanofi (France) (SAN.PA) Linked To Omega Pharma NV (0OMEP.BR) Sale; Deal Could Cost More Than $5.3 Billion 8/29/2014
Luye Pharma Buys Majority Stake In Beijing Jialin For $599 Million 8/29/2014
Achillion Pharmaceuticals, Inc. (ACHN) Hits One Year High After Rumors Gilead Sciences, Inc. (GILD) Might Buy It Out 8/28/2014